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Summary 
To examine the role of light chains m  early B  cell development we combined lkAG-1  and k5 
mutations  to  produce  mice  that  expressed  neither  conventional  nor  surrogate  light  chains 
(RAG-1 -/-, k5-/-).  Unique  heavy and light chain genes were then introduced  into the dou- 
ble and single mutant backgrounds.  Membrane immunoglobulin  (Ig)l* (might)  associated with 
Igot-Ig[3 but was unable  to activate the pre-B  cell transition  in RAG-1  /  k5 -/-  mice. Either 
k5 or kappa hght chains were sufficient to complement this deficiency. Therefore hght chains 
are absolutely required  for a functional  Ig signaling module  in early B  cell development.  Our 
data provide direct evidence for the existence of two pathways for induction  of early B  cell de- 
velopment: one which is acnvated through  surrogate light chains and mlgl*, and an alternative 
pathway which uses conventional light chains and might. 
L 
Ymphocyte development in the bone marrow advances 
through  a series of ordered  events,  ultimately resulting 
in B  ceils that express Ig Ag receptors (1, 2). Although little 
is known about the initial lineage commitment events, pro- 
gression along later stages in this pathway is guided by the 
expression of productively rearranged  Ig heavy chains,  and 
the  membrane  Igbt  (mlgbt)-associated  Igor  and  Ig~  signal 
transducers  (3, 4). 
The earliest event thought  to be induced  by mlgl,  t  is al- 
lelic exclusion  (5). Upon a productive VH--+DJH rearrange- 
ment  and  subsequent  mlgl,  t  expression,  further  rearrange- 
ments at other heavy chain loci are inhibited,  resulting in 
B  cells  with  clonotypic  receptors  (6-8).  Recent  work  in 
several  laboratories  has  shown  that  in  addition  to  mlgp~, 
Igor, and  Ig~, the  surrogate  light  chain  kS  is also required 
to establish allellc  exclusion  (9-1l).  Thus,  allelic  exclusion 
is thought  to be regulated by a complex formed by mlgbt, 
k5, V  pre-B, and the Igo~-Ig[3 signal transducer. 
After  activation  of allelic  exclusion,  mlgD induces  pro- 
genitor B  (pro-B)  cells to progress to the next stage in de- 
velopment  and  become  precursor  B  cells  (pre-B)  (6,  12, 
13). The pre-B cell transition appears to be activated by the 
same B  cell receptor (BCR)  components that trigger allelic 
exclusion. Mice that cannot produce a functional mlgl~, (8, 
14-16),  or the  Igo~-Ig]3  signaling  complex  (3,  17,  18)  ex- 
hibit a profound block in B  cell development at the pro-B 
cell  stage.  In  contrast  the  requirement  for  the  surrogate 
light  chain  in the  pre-B  cell  transition  is not  absolute  and 
k5  deficiency  results  in  an  incomplete  block  in  develop- 
ment:  k5 -/  pro-B  cells  leak  through  to  the  pre-B  cell 
stage  and  ultimately  populate  the  mature  B  cell  compart- 
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ment  (1%  20).  To  explain  the  leaky phenotype  found  in 
k5 -/  mice, Melchers, Rajewsky, and colleagues have pro- 
posed that there  are two pathways for B  cell development 
(19,  21).  Under  normal  circumstances  mlgb~  would  be 
paired  with  the  surrogate  light  chains,  k5  and  Vpre-B,  to 
produce  an active pre-B cell receptor.  Alternatively,  when 
the  surrogate  chains  are  not  expressed,  or  when  a  light 
chain  rearranges  early,  a  salvage  pathway  would  be  acti- 
vated.  This  secondary  pathway  would  require  that  mlgb~ 
pair with  conventional  light  chains  to  produce  the  func- 
tional pre-B cell receptor complex. 
To test this hypothesis we studied B  cell development in 
mice restricted  to  expressing mlgp~ alone,  or in  combina- 
tion  with  either  K light  chain,  or  surrogate  light  chains. 
Here  we  report  direct  evidence  for the  existence  of two 
pathways that mediate early B  cell development. 
Materials and Methods 
Constructs and Mice.  The  transgenic  constructs  used  for  the 
experiments reported  here have been  described  elsewhere  (22). 
The l&otype produced by the hea  W and light chain combination 
is detected with the 54. l  monoclonal anubody (23).  R.AG-I-: 
mice were a gift from Dr. David Baltimore (Massachusetts  Insti- 
tute  of  Technology,  Cambridge,  MA)  and  E.  Spanopoulou 
(Mount  Sinai  Me&cal School, New York). k5  '  mice were a 
gift from Dr. F.  Melchers  (The Basel  Institute for Immunology, 
Basel, Switzerland)  and provided by Dr. M.D.  Cooper (Umver- 
sl  W of Alabama at Birmingham, Birmingham, AL). All mice were 
bred and maintained under specific pathogen-free conditions. 
Flou, Cytonletry.  The following annbodles were used for sur- 
face staining of bone marrow B cells: PE-B220 (Pharmmgen, San 
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ture Collecuon, Rockville, MD), biotin-labeled anti-human IgM 
(heavy chain-specific DA4.4 clone; Southern Biotechnology As- 
sociates,  Inc., Birmingham,  AL), and  biotin-labeled antiidiotype 
(54.1  hybridoma;  a  gift from Dr.  D.Nemazee,  National Jewish 
Center  for  Immunology  and  Respiratory  Medicine,  Denver, 
CO). Biotin-labeled antibodies were visualized with streptavidln- 
RED670  (GIBCO-BRL,  Galthersburg,  MD).  Data  were  col- 
lected  on  a  FACScan  ® (Becton  Dickinson  and  Co.,  Mountain 
View, CA) and were analyzed using CellQuest software (Becton 
Dickinson). 
Intracellular Human IgM Expression.  The  presence  of  human 
IgM  hea  W  chain  in  the  cytoplasm  of B  cells  was  verified by 
FACS  ®,  as  previously described  (24).  Briefly,  B  cells from  the 
bone  marrow  of 6-8-wk-old  mice were  first  stained  with  PE- 
B220  and  FITC-CD43  ($7  hybridoma)  antibodies.  The  cells 
were then  fixed with  4% paraformaldehyde  in PBS  and perme- 
abilized with  1%  saponin.  Anti-human  IgM  was  then  used  to 
stain  the treated B  cells.  Data  acquisition was performed with a 
FACScan  ® and  appropriate  gating  and  analysis  was  done  w~th 
CellQuest software. 
Abelson  Virus Transformation of Bone Marrow cells.  Bone  mar- 
row from 6-8-wk-old mice was transformed with Abelson MuLV 
(A-MuLV) in accordance with pubfished protocols (25).  Briefly, 
2  X  107 bone marrow cells were suspended in 6 ml of complete 
medium  (1LPMI  1640  supplemented  with  10%  FCS,  50  U/ml 
penicillin,  50  txg/ml streptomycin,  and  50  tiM  2-ME),  treated 
with 2  ml of virus stock,  and  plated  onto  100-mm plastic petri 
dishes (Coming Inc., Cornmg NY). The dishes were left at 37°C 
in a  humidified 5% CO2  atmosphere  for 2  h,  and  then  4  ml of 
medium  was  added.  Transformed  B  cells  were  maintained  in 
complete medium. 
Immunopredpitation and Immunoblotting.  A-MuLV-transformed 
bone  marrow  cells  were  lysed  in  1%  n-dodecyl-B-D-maltoside 
A 
Transgene:  " 
Background:  WT  RAG-l-/-  Z5-/-  X5-/- RAG-l-l- 
B 
Transgene:  Ig~t 
Background:RAG-  14- 
anti-CD43 
anti-human IgM 
°  k 
anfi-Idiotype 
Iglx  Iglx  YS:VV Ig~t:Ig  I] 
KS-l-  ~,5-/- RAG- 1-/-  k5-/- RAG- 1-L 
IgM 




2026  Activation of Pre-B Cell Transition 
Figure  1.  Bone marrow cells from 6-8- 
wk old mace were analyzed by staining with 
PE-antl-B220,  FITC-antl-CD43,  biotin- 
anti-human  IgM  and  blotm-antl-X&otype 
(54.1) antibodies.  The lymphocyte popula- 
non  was  gated  according  to  standard  for- 
ward- and  size-scatter values  For the PE- 
anti-B220/  FITC-antl-CD43  profiles,  the 
numbers  on the upper  left corner represent 
the  percentages  of  gated  lymphocytes  m 
each quadrant.  (A) FACS  ® profiles from all 
the control animals. (B) B cell development 
in the bone marrow oftransgemc mice defi- 
cient for RAG-1 and h5. Transgene: 
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Figure 2.  Intracellular  expres- 
sion of  the human ~ heavy chain 
transgene.  Cells, staaned wath 
PE-ann-B220  and  FITC-ann- 
CD43,  were  fixed, permeabi- 
lazed, and  subsequently stained 
with  bmtm-antl-human  IgM. 
Gating was on CD43  + cells 
(Anatrace,  Maumee, OH), 50 mM Tris,  pH 6.8,  100 mM NaC1. 
Insoluble matenal was removed by centrifugation. The superna- 
rant was  incubated with rabbit antiserum to human IgM (5Fc  m) 
(Cappel  Research Products, Durham, NC) and protein A agarose 
(Pierce  Chemical  Co.,  Rockford,  IL)  for 2  h  at  4°C.  Immune 
complexes were  collected,  washed  in  lysis buffer,  separated  by 
10% reducing SDS-PAGE, and transferred  to Immobilon-P (Mil- 
hpore Corp., Bedford, MA) m a semi-dry system (Owl Scientific, 
Cambndge, MA). After incubation with anti-human IgM (Cap- 
pel),  anti-Igor,  or anti-IgJ3  (26) blotting antibodies,  labeled  pro- 
terns were visualized with 12SI-protein A (New England Nuclear, 
Boston, MA) using x-ray film. 
Results 
Light  Chains  Are  Necessary for  the  Pro-B  to  Pre-B  Cell 
Transition.  In the  bone  marrow,  induction  of the  pre-B 
cell  transition  coincides  with  loss  of expression  of CD43, 
and  so pre-B  cells  are  B220+CD43 -  whereas  pro-B  cells 
are  B220+CD43 +  (Fig.  1  A  and  [27]).  To  determine 
whether light  chains are required  for early B  cell develop- 
ment we first bred together RAG-l-/-  and k5 -/- targeted 
mice to create  double-deficient  animals  (RAG-1  /-k5-/-). 
In this background there  are no heavy or fight chain gene 
rearrangements because of the RAG-1 deficiency (15), and 
k5 is not expressed  (19, 20). The phenotype of the RAG- 
1-/-k5 -/-  animal resembles  that  of the  RAG-1  /-  mice, 
in that B  cells  are arrested  at the B220+CD43 + pro-B cell 
stage (Fig.  1 A). 
The  developmental  defect  observed  in  the  RAG-1 -/- 
mice  is  strictly  due  to  their  inability  to  perform  Ig rear- 
rangements,  and  it  can be  overcome by the  addition  of a 
pre-rearranged  mIglx transgene  (12,  13).  The same human 
mlgjx transgene  also facilitated  the pre-B  cell transition  in 
K5 -/-  mice  (Fig.  1  B).  However,  it  had  no  effect  in  the 
double-mutant  background:  FACS  ® analysis  of the  bone 
marrow of TG.mlglx RAG-1-/-X5 -/-  mice revealed only 
B220+CD43 + pro-B cells (Fig.  1 B).  These cells  expressed 
human  Ig~ but  did  not  transport  it  to  the  cell  surface: 
human mIgp~ was entirely intracellular in TG.mIgp. RAG- 
1-/-k5 -/-  pro-B  cells  (Fig.  2)  as  well  as  in  TG.mIg~z 
RAG-1-/-k5 -/- A-MuLV-transformed B cell fines (data not 
shown).  Since  the  only difference  between  the  TG.mlgl* 
RAG-1 -/- and the TG.mlgl* RAG-1-/-R5 -/-  mice is the 
expression of  k5 in the former, we conclude that in the absence 
of conventional fight chains the surrogate  chains are abso- 
lutely required to deliver the signal for B  cell development. 
To determine whether K light chains could substitute for 
surrogate fight chains in the double-mutant mice we com- 
bined  a  K  light  chain  transgene  with  mlgt,  transgene 
(mlglx+K) in the RAG-1  /-k5 -/-  double-deficient mice. 
Addition  of the  light  chain  was  found  to  rescue  B  cell 
development  in  this  background:  the  bone  marrow  of 
TG.mlgI~+K  RAG-1-/-R5 -/-  mice  contained  B220  + 
CD43- pre-B cells,  which carried transgenic  IgM on their 
surface  and  stained  positive  for the  antiidiotyplc  antibody 
54.1  (Fig.  1  B).  Therefore,  the  K light  chain is  able  to re- 
constitute  B  cell  development  by  substituting  for  k5  an 
RAG-1-/-R5 -/  double-deficient mice. 
The  Pre-BCR  Is Assembled  but  Does  Not  Function in  the 
Absence of Light Chains.  One explanation for the observa- 
tion  that  mIg~ is  inactive  in  the  P,.AG-1 -/  k5 -/-  back- 
ground might be that fight chains are required for assembly of 
the early BCR.  To determine whether mIglx was associated 
with  Igot-IgJ3  m  the  absence  of light  chains  we  per- 
formed  immunopreclpitation  experiments  on  A-MuLV- 
transformed cells derived from TG.mlglx tLAG-1-/-k5  /- 
bone  marrow.  We  found no  difference  in  the  amount  of 
Igci and Igj3 that was associated with the heavy chain in the 
presence  or  absence  of light  chains  (Fig.  3).  However,  it 
was only in the TG.mlglx RAG-i-/--derived lines that we 
saw the fully glycosylated surface form of Ig[3 coprecipatate 
with human IgM (Fig. 3).  The two glycosylated Ig[3 bands 
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Figure  3.  Light  chains are not necessary for proper assembly of the 
early BCIL, since Ig~ and Ig[3 can associate with mlgt* in thmr absence. 
lg receptor complexes were immunopreopltated from A-MuLV trans- 
formed B cells derived from the bone marrow of transgenlc nuce. Imnm- 
nopreclpltauons were done with protein A- coupled rabblt anu-human 
IgM and  the  membranes were subsequently blotted with anu-human 
lgM, ann-mouse  lgM (control), anU-Ig~ and ann-lgJ3 antlbo&es (26). 
s  f,  surface form; of., cytoplasmic  form. 
were absent in the lanes  which represent  precipitates  from 
TG.mIgb~ R.AG-1-/-R5-/--derived  B  cell  lines  (Fig.  3), 
and  only  visible  after  prolonged  exposure  in  TG.mlgb~ 
h5  /-  A-MuLV cell lines which only rarely rearrange  and 
express conventional light chains (not shown). M1 four Ig[3 
bands  collapse  into  one  upon  digestion with  endoglycosi- 
dase  H.  Thus association of Igo~-Ig[3 with the  heavy chain 
is  hght  chain  independent,  but  cell  surface  transport  re- 
quires either h5 or conventional light chains. 
To  directly  assess  whether  pre-BCR  function  requires 
light chains we introduced a mlgb~:Ig  ~  chimeric transgene 
into  the  RAG-1-/-R5  /-  background  (TG.mlgl.~:Ig[3 
P,.AG-1-/-h5  /-).  The  Ig~  component  of this  transgene 
encodes a membrane-bound Ig with a transmembrane mu- 
tation  that  prevents  its  normal  association  with  Ig~-Ig[3. 
The  cytoplasmic  domain  of the  chimeric  protein  is  en- 
coded by Ig[3.  Signaling by the  chimeric  mlgl~:Ig[3 trans- 
gene is through tyrosine residues in the Ig~ tail and is inde- 
pendent  of endogenous  Igot-Igl3 (22).  Thus,  this  chimeric 
receptor is preassembled into a functional subunit and does 
not have to associate with Igo~-Ig~ to induce the pre-B cell 
transition.  Although  the  chimeric  receptor  was  active  m 
the RAG-1 -/  background (22) it was completely inactive 
in  RAG-1-/-)~5  /  mice  (Fig.  1  B).  There  were  no 
B220+CD43  cells  in  the  bone marrow  of TG.mlgD:Ig[3 
I<AG-1  /  h5 -7-  mice  (Fig.  1  g).  In  addition  transgenic 
mlgbt:Ig[3 was not expressed on the cell surface in the dou- 
ble-mutant  background  although  transgenlc  might  was 
found in large quantities in the cytoplasm of TG.mlgb~:Ig[3 
RAG-1-/-R5 -/-  pro-B  cells  (Fig.  2).  We  conclude  that 
light chains are not required  to assemble a pre-BCR  com- 
plex and must therefore be necessary for some other limit- 
ing step, such as cell surface transport or interaction with an 
as yet unknown cognate receptor. 
Discussion 
The antigen receptor found on mature B  cells is a com- 
plex  structure.  It  is  composed  of an  Ig  heavy  and  light 
chain  heterodimer,  and  the  Iget-Ig~  signal  transducers 
which  are  noncovalently associated  with  mlg~  (28).  The 
heavy and light  chains bind  antigen but have  no signaling 
capacity on their  own,  and require  Igo~ and Ig~ to induce 
the phosphorylation of non-receptor tyrosine kinases which 
give rise to physiologic responses (26, 29-33). 
A receptor similar to the mature BCR is thought to me- 
diate  several key developmental  events in  early B  cells.  As 
in the mature 13CR the signaling module of the pre-BCR 
is the Igot-lg~ heterodimer: both Igor and Igl3 are expressed 
very early in B  cell development  (34-36),  and they associ- 
ate  with  mIg~  as  soon  as  it  is  produced  (this  paper,  and 
[28]).  Furthermore,  the IgoL and IgJ3 proteins are necessary 
and sufficient to induce  early 13  cell  development  (17,  18, 
22,  24),  and  the  mechanism  by  which  the  Ig~-IgJ3  het- 
erodimer  activates  early  13  cell  transitions  is  analogous  to 
that  used  by  the  mature  BCR  (31-33).  Both  have  a  re- 
quirement  for receptor  tyrosine phosphorylation  (22,  24), 
syk  kinase  signaling  (37,  38)  and  receptor  cross-linking. 
However, the molecular identity of the pre-BCR ligand, as 
well as the  receptor components required  for recogmtion, 
have been the subject of debate.  For example,  results from 
gene-targeting experiments  (19,  20)  as well as experiments 
with transformed t3 cell lines  (39)  suggested that the surro- 
gate light  chains  h5  and VpreB are important  components 
of the  early 13  cell  receptor.  In addition,  signaling  by  the 
early B cell receptor appears to be dependent on h5 in pro- 
B  cells,  as there is no allelic  exclusion in these cells in h5  / 
mice  (9,  10).  But  desDte  the  lack  of allelic  exclusion  in 
pro-B cells  in k5  /-  mice,  the few B  cells  that do mature 
in this mutant background express a single heavy and light 
chain combination (19). One way to account for the differ- 
ences  in  allelic  exclusion  between  ~.5 -/-  pro-B  cells  and 
h5  '- mature B  cells would be if the combination ofmlg~ 
with light chains could also produce a functional pre-B cell 
receptor.  According to this  model  the  mIgl~-Igc~-IgJ3 sig- 
naling module of the pre-13 cell receptor would be recog- 
nized and triggered when combined with either a conven- 
tional or a surrogate light chain. 
Consistent with  this  idea,  targeting of the  h5  gene  does 
not  abrogate  13  cell  development  completely  (19),  and  so 
h5 is not indispensable  for either allelic exclusion or 13 cell 
development.  Our  finding  that  a  heavy  chain  transgene 
could facilitate the pre-B cell transition in h5 -/- mice is in 
agreement  with  Grawunder  et  al.  (40)  though  not  with 
Corcos et  al.  (11).  Both our results  and those  reported by 
Grawunder  (40)  support the idea that the leaky phenotype 
in  )~5 -/  mice  can be  explained  by stochasnc  V(D)J  rear- 
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tions in  any single  developing B  cell is  a  rare  event,  yet it 
would be  essential for pre-B  cell  development  to  proceed 
in the absence of)~5. Thus it would be expected that intro- 
ducing  an  already  rearranged  heavy  chain  into  the  R5 -/- 
background  would  increase  the  number  of pre-B  cells  by 
reducing  the  requirement  for activation  of the  transition 
to  successful  completion  of  light  chain  gene  rearrange- 
ments.  Our finding  that  a transgenic  K light  chain  was re- 
quired  for  mlgb~  to  acnvate  the  pre-B  cell  transition  in 
ILAG-1-/-k5 -/-  mice  provides  further  support  for  this 
idea,  because it shows  that in  the  absence  of the  surrogate 
light  chains,  conventional  light  chams  are  indeed  essenual 
for pre-BCR function  in  early B  cell  development.  When 
neither surrogate light chains nor conventional light chains 
are expressed,  B  cell development cannot proceed past the 
pro-B  cell stage. 
What is the role of the light chain in developing B  cells? 
Our experiments show that light chains  are  not simply  fa- 
cilitators  for assembly of the mlgl.t,  Igc~-Ig[3  complex.  The 
mlgl,z transgene that was inactive in RAG-1-/-k5  -/-  pro- 
B  cells,  was  associated  with  Igot-Ig[3.  Further,  a  chimeric 
mlgb~:Ig[3  transgene,  that  encodes  a  preassembled  BC1L 
that  does  not  require  endogenous  Igc~-Ig[3  for  signaling, 
was also inacnve in the RAG-1-/-k5  -/-  mice.  Therefore, 
it appears  that ~5 or conventional light chains are not nec- 
essary  for  pre-B  cell  receptor  assembly  but  they  are  re- 
quired to produce a receptor which is competent to signal. 
Studies  with  secreted  Igs  and  B  cell  lines  have  shown 
that  light  chains  are  required  to  release  the  heavy  chain 
from immunoglobulm binding protein  in the  endoplasmic 
reticulum  (41)  and for heavy chain transport  (42-44).  Mu- 
tant cell lines that do not produce light chains fail to secrete 
the heavy chain (42-44).  This transport function appears to 
be  independent  of  assembly  and  antigen  binding  since 
point  mutations  in  conserved  light  chain  residues  alter 
transport  but  not  antigen  binding  (45).  If signaling by  the 
early BCR  is a cell surface event,  then the role of the light 
chain,  either surrogate  or conventional,  may be  limited  to 
transporting the BCR complex to the cell surface. The ob- 
servation that the inactive mIgbt-Igot-Ig[3 complex remained 
intracellular in both bone marrow and A-MuLV-transformed 
RAG-1-/-R5 -/-  B  cells  supports  the  hypothesis  that  one 
of the  functions  of the  fight  chain in  early B  cell  develop- 
ment is to transport the receptor to the cell surface.  Never- 
theless, light chains may also contribute  directly to receptor 
activation  as  structural  components  which  are  recognized 
by  the  putative  cross-linker  either  on  the  cell  surface  or 
inside the developing B  cell.  In this model the cross-linker 
must  see  a  structural  element  shared  by  all  conventional 
light chains as well as surrogate light chains. The availability 
of RAG-1-/-R5 -/-  pro-B  cells  which  can  be  comple- 
mented with  combinations  of altered  Ig transgenes  should 
facilitate  the  elucidation  of the molecular mechanisms  that 
control early BC1L function. 
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